The Hormone Side Effect of Long-Term Opioids Few People Talk About

A person taking opioids for months may expect constipation, drowsiness, or nausea. They may not expect a change in libido, erectile function, menstrual cycles, energy, or fertility.

Yet opioids do more than change the way the brain processes pain.

They can also interfere with the hormonal signals connecting the brain, pituitary gland, and reproductive organs. With prolonged exposure, some people develop opioid-induced hypogonadism, a condition in which the body produces inadequate levels of sex hormones.

A 2024 scientific statement from the Endocrine Society describes hypogonadism as a well-recognized consequence of opioid exposure, while also noting that important questions remain about how frequently it occurs in different groups and how best to manage it.

The Effect Starts in the Brain

Testosterone and estrogen production depend partly on a chain of hormonal signals known as the hypothalamic-pituitary-gonadal axis.

Opioids can suppress that system.

They reduce the release of gonadotropin-releasing hormone from the hypothalamus. That can lower pituitary hormones such as luteinizing hormone and, in turn, reduce production of testosterone or other sex hormones.

The result can be more than an abnormal laboratory value.

In men, symptoms may include reduced libido, erectile dysfunction, fatigue, reduced muscle mass, infertility, depression, or loss of bone density. Women may experience changes in menstrual cycles, reduced libido, fertility problems, or other symptoms associated with reduced sex hormone activity. Evidence in women is more limited than in men, which is one reason the problem can be harder to recognize.

Fatigue Does Not Always Point Back to Pain

One reason opioid-related hormone problems can be missed is that many of their symptoms have other possible explanations.

Fatigue may be blamed on chronic pain. Low mood may be attributed to poor sleep. Reduced sexual interest may be blamed on stress, aging, or relationship difficulties.

Daniel Ghiyam, M.D., founder of MedPodLA and a physician focused on hormone and metabolic health, has cautioned against relying too heavily on whether a lab result simply falls inside a standard reference range.

“Most standardized labs use reference ranges that are based on averages from the general population.”

His broader point is that laboratory values need to be interpreted alongside symptoms and the individual’s medical context rather than treated in isolation.

That becomes particularly relevant when someone develops new fatigue, sexual dysfunction, or other unexplained symptoms during long-term opioid therapy.

Men Appear to Be Particularly Vulnerable

Research estimates vary considerably because studies use different opioids, doses, populations, and definitions of low testosterone.

A 2025 review of opioid-induced androgen deficiency in men found reported prevalence ranging from roughly 20 percent to 80 percent. The authors emphasized that the risk depends on factors such as opioid type, duration of use, age, and how testosterone deficiency is defined.

An earlier meta-analysis estimated hypogonadism in approximately 63 percent of predominantly male patients included in 15 studies, although those data should not be applied as a universal rate for everyone taking opioids.

Long-acting opioids may carry greater risk than some short-acting formulations. The Endocrine Society statement also notes that buprenorphine appears to have milder effects on the reproductive hormone system than some other opioids.

That does not mean someone should switch or discontinue an opioid based on hormone concerns alone.

Hormones Should Be Part of the Clinical Picture

Bruce Dorr, M.D., an OB-GYN with additional expertise in hormone health, has emphasized that hormonal factors deserve appropriate consideration when symptoms could have several explanations.

“They need to be at the forefront of, or at least a piece of, an evaluation.”

Although Dr. Dorr was discussing women experiencing hormonal changes around perimenopause, the principle applies more broadly. Symptoms such as low libido, fatigue, mood changes, and menstrual disruption should not automatically be attributed to age, stress, or pain without considering hormonal cause.

For someone taking opioids long term, medication exposure becomes another relevant part of that history.

A Testosterone Test Is Not the Whole Evaluation

Someone who suspects a hormone problem should not simply order testosterone online or begin replacement therapy based on a single result.

Diagnosis requires context.

Clinicians may consider symptoms, opioid dose and duration, medical history, other medications, and appropriately timed laboratory testing. Depending on the patient, evaluation may include testosterone or estradiol along with pituitary hormones and other tests needed to distinguish opioid effects from other endocrine conditions.

Claudia Arregoytia, M.D., N.D., a functional medicine physician and certified hormone specialist at Brilliant Health Institute, summarizes the individualized approach this way:

“You are not your diagnosis. My job is to listen carefully, then build a plan around your actual life and your actual goals.”

That principle is especially relevant when symptoms could come from several sources at once.

Low testosterone, for example, may be associated with obesity, pituitary disorders, severe illness, sleep problems, aging, certain medications, and other conditions in addition to opioid exposure.

Treatment Is Not Automatically Hormone Replacement

Finding low hormone levels does not automatically mean testosterone or another hormone should be prescribed.

The first step is understanding why the abnormality is present and whether treatment is clinically indicated.

For some patients receiving opioids for chronic pain, clinicians may reconsider the opioid regimen as part of a broader pain management plan. That could include physical rehabilitation, nonopioid medications, psychological strategies, interventional treatments, or other approaches.

Rab Nawaz, M.D., an expert contributor to MyOpioidRecoveryTeam, has described why chronic pain treatment often needs that wider perspective:

“Chronic pain requires multimodal treatment that addresses biological, psychological, and functional dimensions simultaneously.”

Reducing opioid exposure may allow the reproductive hormone axis to recover in some people, but the timing is variable. More importantly, long-term prescribed opioids should not be abruptly stopped simply because a hormone problem is suspected. 

OUD Medication Is a Different Situation

Hormone concerns also need to be handled carefully in people receiving methadone or buprenorphine for opioid use disorder.

These medications can affect endocrine function, but they are also evidence-based treatments that reduce the harms associated with untreated OUD.

A person should not stop methadone or buprenorphine because of fatigue, sexual symptoms, or an abnormal hormone result without discussing the situation with the treating clinician.

The safer approach is to evaluate the endocrine problem while protecting the stability gained from OUD treatment.

Physical dependence on prescribed opioids or medications for OUD also does not automatically mean addiction. The diagnosis of OUD depends on a broader pattern of problematic opioid use and its consequences.

The Endocrine Effects May Extend Beyond Testosterone

Sex hormones receive much of the attention, but researchers are examining other endocrine effects as well.

Opioids can suppress the hypothalamic-pituitary-adrenal axis, which regulates cortisol. Studies have reported low cortisol levels or abnormal responses to testing in some people taking opioids, although the Endocrine Society says the true clinical importance and frequency of opioid-induced adrenal insufficiency remain less certain than the evidence for hypogonadism.

Research has also raised concerns about bone health. Reduced sex hormones, together with other opioid-related factors, may contribute to loss of bone density and fracture risk.

These connections are another reason persistent unexplained symptoms deserve evaluation rather than being written off as simply part of living with chronic pain.

Sometimes the Side Effect Is Hiding in Plain Sight

A person taking opioids may never connect declining libido, erectile problems, menstrual changes, or persistent fatigue with their pain medication.

Their clinician may not immediately make the connection either.

But long-term opioid exposure can influence systems far beyond pain perception.

Recognizing that possibility does not mean every symptom is caused by opioids, nor does it mean opioid treatment should automatically stop. It means hormone health deserves a place in the conversation when symptoms and medication history point in that direction.

Sometimes improving opioid care begins by asking about something that appears completely unrelated to pain.